Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population.

Shen, De-Liang

Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population. [electronic resource] - Journal of cardiovascular pharmacology Mar 2016 - 232-6 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1533-4023

10.1097/FJC.0000000000000337 doi


Adenosine--adverse effects
Aged
Aged, 80 and over
Asian People--genetics
Biotransformation
Chi-Square Distribution
China
Clopidogrel
Coronary Artery Disease--ethnology
Cytochrome P-450 CYP2C19--genetics
Drug Monitoring--methods
Female
Genotype
Hemorrhage--chemically induced
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Percutaneous Coronary Intervention--adverse effects
Pharmacogenomic Testing
Phenotype
Platelet Aggregation Inhibitors--adverse effects
Platelet Function Tests
Polymorphism, Genetic
Risk Factors
Ticagrelor
Ticlopidine--adverse effects
Treatment Outcome